Living with HIV in the United States can be challenging—not just physically, but mentally and emotionally. Every day, millions of Americans face the stress of daily medication, potential side effects, and fear of stigma or disease progression. According to the CDC, 31,800 new HIV infections occurred in the U.S. in 2024 alone, while 1.2 million people are currently living with the virus. Common early symptoms like fatigue, swollen lymph nodes, fever, and weight loss can be subtle but worrying.
But what if there was a better way to manage HIV—one that didn’t require daily pills?
Long-acting HIV treatments are offering new hope. With just a few injections a year, these therapies are changing how Americans live with HIV. Want to learn more about this game-changing option? Click to discover how it works and if it's right for you.
How Daily HIV Pills May Be Holding You Back
Taking medication every single day isn’t easy. Life gets busy, and missed doses can lead to drug resistance or viral rebound. In fact, about 30% of HIV-positive Americans report trouble sticking to daily regimens. Long-acting injectable options like Cabotegravir and Rilpivirine (CAB/RPV) offer an alternative—just one shot a month or every two months to stay on track.
Imagine the freedom of not having to carry pills everywhere or remember every dose.
Concerned About Persistent HIV Symptoms?
Symptoms like fever, night sweats, and fatigue can be frustrating and concerning—especially if your viral load isn’t suppressed. Yet, only 65% of Americans diagnosed with HIV had their viral load fully suppressed in 2025.
New long-acting therapies have achieved over 94% suppression rates in clinical studies lasting up to 2 years. Fewer doses, fewer symptoms, and better control—what’s not to love?
Find out how you can manage your symptoms more effectively.
Could Monthly Injections Protect Your Health and Others?
With 13% of Americans with HIV—around 158,249 people—unaware of their status, and 67% of new infections in 2024 linked to male-to-male sexual contact, transmission remains a concern. Monthly injections keep your viral load undetectable, preventing both disease progression and transmission to others. Revolutionize your care and make a difference.
Tired of the Stigma Around HIV Treatment?
HIV-related stigma affects many, with social and structural issues like discrimination and limited healthcare access driving inequities, especially among Black and Hispanic/Latino communities, who accounted for 47% of new infections among women in 2022. Long-acting treatments offer a discreet option—no daily pills to hide. Regain your confidence and privacy.
How Do Monthly Injections Fit into Your Busy Life?
New HIV infections in the U.S. dropped 12% from 2018 to 2025, partly due to better treatment access, but daily ART can still be tough for busy individuals, like the 30% of young people aged 13-24 who saw a significant decline in infections. Monthly injections mean fewer doses and less stress—just one shot every 4-8 weeks. See how this revolutionary option fits your lifestyle!
Simplify Your HIV Journey—Without Compromising Results
Managing HIV shouldn’t feel like a full-time job. With long-acting treatments like CAB/RPV, approved by the FDA in 2021, you can maintain viral suppression with fewer doses. A 2024 study showed it’s even effective for those with past adherence challenges, offering hope to many. Simplify your care and focus on living your best life!